Cullinan Associates’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,905
Closed -$320K 246
2023
Q2
$320K Sell
4,905
-1,145
-19% -$70.9K 0.02% 217
2023
Q1
$369K Sell
6,050
-7,512
-55% -$470K 0.02% 207
2022
Q4
$776K Sell
13,562
-98,041
-88% -$5.75M 0.04% 175
2022
Q3
$6.41M Buy
111,603
+3,701
+3% +$242K 0.4% 67
2022
Q2
$7.28M Buy
107,902
+7,365
+7% +$564K 0.45% 64
2022
Q1
$9.02M Buy
100,537
+14,167
+16% +$1.24M 0.47% 59
2021
Q4
$7.66M Buy
+86,370
New +$6.95M 0.39% 73

Other funds holding CTSH

Cullinan Associates's CTSH Position: Q3 2023 in Review

Cullinan Associates sold out of Cognizant (CTSH) in Q3 2023, closing a stake of 4,905 shares — an estimated $320K sold.

Cullinan Associates first reported a position in CTSH in Q4 2021 and held it in 7 quarters. The position peaked at $9.02M in Q1 2022. 851 funds tracked by Wall St. Rank hold CTSH as of Q3 2023.

  • Cullinan Associates reported no remaining Cognizant position as of Q3 2023 after selling out during the quarter.
  • Cullinan Associates sold 4,905 Cognizant shares in Q3 2023, an estimated $320K.
  • Cullinan Associates first reported a position in Cognizant in Q4 2021 and held it in 7 quarters.
  • Cullinan Associates's Cognizant position peaked at $9.02M in Q1 2022.
  • 851 funds tracked by Wall St. Rank held Cognizant as of Q3 2023.

Based on Cullinan Associates's 13F filing for Q3 2023, filed 11 Oct 2023.